LKB1 promotes lung adenocarcinoma cell senescence by suppressing the O-GlcNAc glycosylation-mediated activation of telomerase.

Gu L, Liu M, Li Y, Zhou H, Wang Y, Xu ZX

Open source

DOI
10.3389/fphar.2026.1952846
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1952846,
  title = {LKB1 promotes lung adenocarcinoma cell senescence by suppressing the O-GlcNAc glycosylation-mediated activation of telomerase.},
  author = {Gu L and Liu M and Li Y and Zhou H and Wang Y and Xu ZX},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1952846},
  url = {https://doi.org/10.3389/fphar.2026.1952846}
}

RIS

TY  - JOUR
TI  - LKB1 promotes lung adenocarcinoma cell senescence by suppressing the O-GlcNAc glycosylation-mediated activation of telomerase.
AU  - Gu L
AU  - Liu M
AU  - Li Y
AU  - Zhou H
AU  - Wang Y
AU  - Xu ZX
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1952846
UR  - https://doi.org/10.3389/fphar.2026.1952846
ER  - 

APA

L, G., M, L., Y, L., H, Z., Y, W., & ZX, X. (2026). LKB1 promotes lung adenocarcinoma cell senescence by suppressing the O-GlcNAc glycosylation-mediated activation of telomerase.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1952846

Source records